PharMolix
PrivateLast Round
Angel
Aug 14, 2024
Company Overview
PharMolix is a biotechnology company that develops AI-powered foundation models and conversational assistants for the biomedical and drug discovery industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharMolix Comparables
Compare PharMolix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EvolutionaryScale | 81% | |
| Genesis Molecular AI | 76% | |
| Cradle | 74% | |
PharMolix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Aug 14, 2024 | ||||
| Seed | Aug 14, 2024 |
Key People
Founding team and executive leadership
PharMolix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dalton Venture | Angel |
| WestSummit Capital | Angel |
| 讯飞创投 | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 17, 2024
Grew 150% QoQ from 2 to 5 employees.
- Aug 14, 2024
WestSummit Capital led the round.
PharMolix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PharMolix's valuation, stock price, and market status.